207 related articles for article (PubMed ID: 11552215)
1. Aprotinin reduces red blood cell transfusion in orthotopic liver transplantation: a prospective, randomized, double-blind study.
Findlay JY; Rettke SR; Ereth MH; Plevak DJ; Krom RA; Kufner RP
Liver Transpl; 2001 Sep; 7(9):802-7. PubMed ID: 11552215
[TBL] [Abstract][Full Text] [Related]
2. The prophylactic use of tranexamic acid and aprotinin in orthotopic liver transplantation: a comparative study.
Dalmau A; Sabaté A; Koo M; Bartolomé C; Rafecas A; Figueras J; Jaurrieta E
Liver Transpl; 2004 Feb; 10(2):279-84. PubMed ID: 14762867
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation.
Ickx BE; van der Linden PJ; Melot C; Wijns W; de Pauw L; Vandestadt J; Hut F; Pradier O
Transfusion; 2006 Apr; 46(4):595-605. PubMed ID: 16584436
[TBL] [Abstract][Full Text] [Related]
4. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
5. Aprotinin in orthotopic liver transplantation: evidence for a prohemostatic, but not a prothrombotic, effect.
Molenaar IQ; Legnani C; Groenland TH; Palareti G; Begliomini B; Terpstra OT; Porte RJ
Liver Transpl; 2001 Oct; 7(10):896-903. PubMed ID: 11679989
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation.
Verma YS; Chauhan S; Bisoi AK; Gharde P; Kiran U; Das SN
Ann Card Anaesth; 2010; 13(2):110-5. PubMed ID: 20442540
[TBL] [Abstract][Full Text] [Related]
7. Hemostasis and blood requirements in orthotopic liver transplantation with and without high-dose aprotinin.
Llamas P; Cabrera R; Gómez-Arnau J; Fernández MN
Haematologica; 1998 Apr; 83(4):338-46. PubMed ID: 9592984
[TBL] [Abstract][Full Text] [Related]
8. [Aprotinin (Antilysin Spofa)--its effect on decreasing hemorrhage in the postoperative period in hip arthroplasty].
Cvachovec K; Sechovská H; Berousek J; Popelka S; Hladíková M
Acta Chir Orthop Traumatol Cech; 2001; 68(5):311-4. PubMed ID: 11759474
[TBL] [Abstract][Full Text] [Related]
9. Randomized, multicentre, double-blind, placebo-controlled trial of the use of aprotinin in the repair of ruptured abdominal aortic aneurysm. On behalf of the Joint Vascular Research Group.
Robinson J; Nawaz S; Beard JD
Br J Surg; 2000 Jun; 87(6):754-7. PubMed ID: 10848853
[TBL] [Abstract][Full Text] [Related]
10. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial.
van der Linden J; Lindvall G; Sartipy U
Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized placebo-controlled trial of aprotinin for elective aortic reconstruction.
Ranaboldo CJ; Thompson JF; Davies JN; Shutt AM; Francis JN; Roath OS; Webster JH; Chant AD
Br J Surg; 1997 Aug; 84(8):1110-3. PubMed ID: 9278654
[TBL] [Abstract][Full Text] [Related]
12. Impact of tranexamic acid vs. aprotinin on blood loss and transfusion requirements after cardiopulmonary bypass: a prospective, randomised, double-blind trial.
Hekmat K; Zimmermann T; Kampe S; Kasper SM; Weber HJ; Geissler HJ; Mehlhorn U
Curr Med Res Opin; 2004 Jan; 20(1):121-6. PubMed ID: 14741082
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of aprotinin in arterial switch operations in infants.
Murugesan C; Banakal SK; Garg R; Keshavamurthy S; Muralidhar K
Anesth Analg; 2008 Sep; 107(3):783-7. PubMed ID: 18713883
[TBL] [Abstract][Full Text] [Related]
14. Randomized study of aprotinin effect on transfusions and blood loss in primary THA.
Colwell CW; Chelly JE; Murkin JM; Stevens D; O'Keefe TJ; Hall R; Parvizi J
Clin Orthop Relat Res; 2007 Dec; 465():189-95. PubMed ID: 17767075
[TBL] [Abstract][Full Text] [Related]
15. [Reduction of the need for blood derivatives in liver transplantation using aprotinin].
Monedero P; Páramo JA; Carrascosa F; Herrero JI; Hidalgo F; Iribarren MJ; García-Pedrajas F
Rev Esp Anestesiol Reanim; 1995 Mar; 42(3):82-6. PubMed ID: 7539932
[TBL] [Abstract][Full Text] [Related]
16. Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study.
Baric D; Biocina B; Unic D; Sutlic Z; Rudez I; Vrca VB; Brkic K; Ivkovic M
Eur J Cardiothorac Surg; 2007 Mar; 31(3):366-71; discussion 371. PubMed ID: 17218108
[TBL] [Abstract][Full Text] [Related]
17. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
18. Coagulation defects do not predict blood product requirements during liver transplantation.
Massicotte L; Beaulieu D; Thibeault L; Roy JD; Marleau D; Lapointe R; Roy A
Transplantation; 2008 Apr; 85(7):956-62. PubMed ID: 18408574
[TBL] [Abstract][Full Text] [Related]
19. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications.
Bakaeen F; Rice D; Correa AM; Walsh GL; Vaporciyan AA; Putnam JB; Swisher SG; Roth JA; Huh J; Chu D; Smythe WR
Ann Thorac Surg; 2007 Sep; 84(3):982-6. PubMed ID: 17720413
[TBL] [Abstract][Full Text] [Related]
20. [The effects of aprotinin. Blood loss and coagulation parameters in orthotopic liver transplantation: A clinical-experimental, prospective and randomized double-blind study].
Kratzer MA; Azad SC; Groh J; Welte M; Haller M; Pratschke E
Anaesthesist; 1997 Apr; 46(4):294-302. PubMed ID: 9229983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
